Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects
Assess the impact of dietary omega 3 free fatty acids and/or letrozole on obese, postmenopausal breast cancer patients.
Breast Cancer
DRUG: Letrozole|DIETARY_SUPPLEMENT: Fish Oil
Change in levels of aromatase target gene., 30 Days|Change in serum levels of PGE2 (prostaglandin E2)., 30 Days
Prospective, comparative, three arm, short term, non-interventional study with correlative biomarker endpoints. Sixty (60) obese (â‰¥ 30 BMI) newly diagnosed ER+ postmenopausal breast cancer patients will be recruited to participate in a short term (30 day) Phase 0 biomarker evaluation study prior to surgical resection.